Evaluating vaccines for HIV prevention using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
Funded at University of Louisiana at Lafayette · NIH-11060162 · Data updated 2026-11-12
This study is looking at how well new HIV/AIDS vaccines work by testing them on Rhesus macaques, which helps researchers understand how to make these vaccines better for people in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,955,151 |
| NIH project number | 75N93020D00008-P00006-759302000004-1 |
| Project ID | NIH-11060162 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals at high risk for HIV infection who may eventually receive vaccines developed from these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to HIV prevention strategies may not benefit directly from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines for HIV/AIDS. By maintaining a breeding colony of Rhesus macaques, the study aims to conduct preclinical evaluations of candidate AIDS vaccines, assessing their effectiveness in generating immune responses. The research will involve thorough testing of vaccine efficacy and identifying factors that could enhance the immune response to these vaccines. This work is crucial for advancing HIV prevention strategies and could lead to breakthroughs in vaccine development.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection in humans.
How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach is both established and effective.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.